| Identification | More | [Name]
N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine methyl ester | [CAS]
137863-89-9 | [Synonyms]
N-[(2'-CYANO[1,1'-BIPHENYL]-4-YL)METHYL]-L-VALINE METHYL ESTER
n-[(2'-cyano-(1,1'-biphenyl)-4-yl)methyl)]valine methyl ester
N-[(2'-CYANOBIPHENYL-4-YL)METHYL]-L-VALINE METHYL ESTER
N-[(2'-Cyano[1,1'-Biphenyl]-4-yl) Methyl]-L-Valine Methyl Ester HCl
N-[[(2∧-CYANO(1.1∧-BIPHENYL)-4-YTHYL )METHYL ESTER]-L-L]EVALINE
N-[[(2'-Cyano(1.1'-Biphenyl)-4
N-[[2'-CYANO(1,1'-BIPHENYL)-4-YTHYL]METHYLESTER]-L-1]EVALINE
N-[[(2''-CYANO(1,1''-BIPHENYL)-4-YL)METHYL]METHYL ESTER]-L-VALINE | [EINECS(EC#)]
604-048-9 | [Molecular Formula]
C20H22N2O2 | [MDL Number]
MFCD08436153 | [Molecular Weight]
322.4 | [MOL File]
137863-89-9.mol |
| Hazard Information | Back Directory | [Uses]
N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine Methyl Ester is an intermediate in the preparation of angiotensin II type 1 receptor antagonists. |
|
|